| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/11/2004 | EP1444203A1 Cannabinoid receptor ligands |
| 08/11/2004 | EP1444202A1 Novel metalloproteinase inhibitors |
| 08/11/2004 | EP1444201A1 2-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors |
| 08/11/2004 | EP1444190A1 Combretastatin a-4 derivatives having antineoplastic activity |
| 08/11/2004 | EP1444010A2 Heteroaromatic carboxamide derivatives for the treatment of inflammation |
| 08/11/2004 | EP1443972A2 Pathological tissue detection and treatment employing targeted benzoindole optical agents |
| 08/11/2004 | EP1443971A2 METHOD OF USING 18080, A HUMAN SERINE CARBOXYPEPTIDASE FAMILY MEMBER |
| 08/11/2004 | EP1443970A2 Promoters exhibiting endothelial cell specificity and methods of using same |
| 08/11/2004 | EP1443967A1 Cyclooxygenase-2 inhibitor/histone deacetylase inhibitor combination |
| 08/11/2004 | EP1443962A2 Method for the treatment of cardiotoxicity induced by antitumor compounds |
| 08/11/2004 | EP1443961A2 Glycoprotein compositions |
| 08/11/2004 | EP1443960A2 Antigen arrays presenting il-5, il-13 or eotaxin for treatment of allergic eosinophilic diseases |
| 08/11/2004 | EP1443956A2 Use of tissue factor agonist or tissue factor antagonist for treatment of conditions related to apoptosis |
| 08/11/2004 | EP1443954A2 Targeted thrombosis by tissue factor polypeptides |
| 08/11/2004 | EP1443943A1 Process for reacting alkaloids and use of the reaction products in the preparation of medicaments |
| 08/11/2004 | EP1443942A1 Pharmaceutical composition for use for the treatment of malignancies comprising in combination a bisphosphonates, a cox-2 inhibitor and a taxol |
| 08/11/2004 | EP1443937A1 Substituted 1,4-benzodiazepines and uses thereof for the treatment of cancer |
| 08/11/2004 | EP1443936A2 Process for the preparation of 3,7-disubstituted-2,3,4,5- tetrahydro-1h-1,4-benzodiazepine compounds |
| 08/11/2004 | EP1443933A2 Treatment of chronic myelogenous leukemia, resistant or intolerant to sti571, involving homoharringtonine alone or combined with other agents |
| 08/11/2004 | EP1443931A1 Methods for treating neoplastic, angiogenic, fibroplastic, and/or immunosuppresive ocular irregularities via administration of methotrexate based medicaments, and ocular iontophoretic devices for delivering methotrexate based medicaments |
| 08/11/2004 | EP1443928A2 Treatment of neurodegenerative diseases and cancer of the brain |
| 08/11/2004 | EP1443927A2 Carboline derivatives as inhibitors of ikb in the treatment of multiple myeloma and other cancers |
| 08/11/2004 | EP1443925A1 Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (pde4) inhibitors |
| 08/11/2004 | EP1443921A1 PRODUCTION OF PURE STEREOISOMERS OF TRICYCLO 5.2.1.0 sp 2.6 /sp -DEC-9-YL XANTHOGENATE AND MEDICAMENTS THEREFROM |
| 08/11/2004 | EP1443914A1 Method and pharmaceutical preparations for reducing the activity of cells |
| 08/11/2004 | EP1443913A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 08/11/2004 | EP1443907A1 Biocompatible polymer blends and uses thereof |
| 08/11/2004 | EP1443904A2 Orally administered pharmaceutical preparation comprising liposomically encapsulated paclitaxel |
| 08/11/2004 | EP1443861A2 Tumor targeted photodiagnostic-phototherapeutic agents |
| 08/11/2004 | EP1443860A2 Carbocyanine dyes for tandem, photodiagnostic and therapeutic applications |
| 08/11/2004 | EP1363677A4 Method of using a variant of vegf receptor to treat psoriasis and to enhance wound healing |
| 08/11/2004 | EP1358182B1 Diazocine derivatives and their use as tryptase inhibitors |
| 08/11/2004 | EP1315708B1 Aminoalkenylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same |
| 08/11/2004 | EP1282638A4 Peptides and derivatives thereof showing cell attachment, spreading and detachment activity |
| 08/11/2004 | EP1259507B1 Pseudopolymorph of (-)-cis-2-(2-chlorophenyl)-5,7-dihydroxy-8 4r-(3s-hydroxy-1-methyl)piperidinyl]-4h-1-benzopyran-4-one hydrochloride |
| 08/11/2004 | EP1251846B1 C-4 carbonate taxanes |
| 08/11/2004 | EP1155003B1 Novel guanidine derivatives as inhibitors of cell adhesion |
| 08/11/2004 | EP1147095B1 2, 3, 4, 5-tetrahydro-1h-[1, 4] benzodiazepine-3-hydroxamic acids as matrix metalloproteinase inhibitors |
| 08/11/2004 | EP1051187B9 Treatment of follicular lymphomas using inhibitors of the lymphotoxin (lt) pathway |
| 08/11/2004 | EP1042294B1 Heterocyclic cytotoxic agents |
| 08/11/2004 | EP1019400B1 Benzo(5,6)cycloheptapyridine compounds useful as farnesyl protein transferase inhibitors |
| 08/11/2004 | EP0989983B1 Benzpyrido cycloheptane compounds useful for inhibition of farnesyl protein transferase |
| 08/11/2004 | EP0894135B1 Multivalent and multispecific antigen-binding protein |
| 08/11/2004 | EP0832101B1 Urethane mediated, gst specific molecular release systems |
| 08/11/2004 | EP0821728B1 Tie-2 ligands, methods of making and uses thereof |
| 08/11/2004 | EP0805682B1 Dermatological use of vitamin d derivatives |
| 08/11/2004 | EP0760657B9 Novel potent inducers of terminal differentiation and methods of use thereof |
| 08/11/2004 | EP0730648B1 HUMAN MUTATOR GENE hMSH2 AND HEREDITARY NON POLYPOSIS COLORECTAL CANCER |
| 08/11/2004 | CN1520424A Immunoglobulins 2 |
| 08/11/2004 | CN1520421A Recombinant tumor specific antibody and use thereof |
| 08/11/2004 | CN1520416A 碳水化合物衍生物 Carbohydrate derivatives |
| 08/11/2004 | CN1520415A Pyrido-pyrido-pyrrolo pyrrolo-indole and pyrido-pyrrolo pyrrolo carbazole derivatives, method for prodn. thereof and pharmaceutical compsns. contg. said derivatives |
| 08/11/2004 | CN1520409A Piperazine oxime derivatives having Nk-1 receptor antagonistic activity |
| 08/11/2004 | CN1520403A Novel polymorph v of torasemide |
| 08/11/2004 | CN1520401A Calcilytic compounds |
| 08/11/2004 | CN1520325A Antitumoral formulations of thioxanthenone |
| 08/11/2004 | CN1520324A Antiangiogenic combination thereapy for treatment of cancer |
| 08/11/2004 | CN1520311A Cancer vaccine contg. cancer antigen based on tumor suppressor gene WT1 product and cationic liposomes |
| 08/11/2004 | CN1520304A Xenogenic oligo of or/and polyribonucleotides as agents for treatment of malignant twnours |
| 08/11/2004 | CN1520303A Turnor therapy with alphavirus-based and high affinity laminin receptor-targeted vectors |
| 08/11/2004 | CN1520302A Method of treating hyperproliferative diseases using active vitamin D analogues |
| 08/11/2004 | CN1520301A Method of treating malignancy associated hypercalcemia using active vitamin D analogues |
| 08/11/2004 | CN1520300A Dihydro-triterpenes in treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain |
| 08/11/2004 | CN1520299A Use of compounds with combined NEP/MP-inbihitory activity in prepan. of medicaments |
| 08/11/2004 | CN1520298A Pyrazolopyrimidines as therapeutic agents |
| 08/11/2004 | CN1520297A Sustained release drug delivery system contg. codrugs |
| 08/11/2004 | CN1520291A Fumaric acid derivatives as NF-Kappab inhibitors |
| 08/11/2004 | CN1520288A Methods for prepn. and use of 1alpha, 24 (S)-dihydroxyvitamin D2 |
| 08/11/2004 | CN1520283A Control of compactability through crystallization |
| 08/11/2004 | CN1519240A Substituted nitrogen contg. heterocycles as inhibitors of P38 progein kinase |
| 08/11/2004 | CN1519028A Biological preparation modified in plasma environment for treating cancer and preparation method |
| 08/11/2004 | CN1519026A Biological preparation modified in plasma environment for treating innocent tumor and preparation method |
| 08/11/2004 | CN1518998A Chinese material medica preparation for treating cancer |
| 08/11/2004 | CN1518996A A series of Chinese traditional medicine for treating blood disease |
| 08/11/2004 | CN1518994A Prescription of Chinese traditional medicine for relieving inflammation, detoxification and cancer prevention |
| 08/11/2004 | CN1518986A Application of isorhamnetin and its ramification in medication for treating tumor |
| 08/11/2004 | CN1518977A Combination of levogyrate bicalutamide |
| 08/11/2004 | CN1161467C Fusion protein with function of resisting tumor and its application |
| 08/11/2004 | CN1161464C Human epidermal growth factor recetor specitic fusion protein and its application |
| 08/11/2004 | CN1161396C Biodegradable low molecular weight triblock polyester polyethylene glocol copolymers having reverse thermal gelation properties |
| 08/11/2004 | CN1161378C Antitumour polypeptide and gene therapy vector composition |
| 08/11/2004 | CN1161377C Giant web bombinator skin peptide and its prepn. and pharmaceutical application |
| 08/11/2004 | CN1161375C Fusion protein with improved combining activity to target cell receptor |
| 08/11/2004 | CN1161374C Cyclopeptides of formulal |
| 08/11/2004 | CN1161360C Tetrazole-containg rapamycin analogs with shortened half-lives |
| 08/11/2004 | CN1161356C Puring inhibitors of cylin dependent kinase 2 and I'kappa'beta-'alpha' |
| 08/11/2004 | CN1161352C Quinazoline derivatives |
| 08/11/2004 | CN1161340C Benzimidazole compounds that are vitronectin receptor antagoninsts |
| 08/11/2004 | CN1161153C Immobilized isomerous tumor vaccine and its preparing process |
| 08/11/2004 | CN1161152C Method and composition useful for inhibition of angiogenesis |
| 08/11/2004 | CN1161135C Medicine for curing carcinoma of stomach |
| 08/11/2004 | CN1161129C I(ex vivo) treatment of allogeneic and xanogeneic T-cells with gp39 antagonists |
| 08/11/2004 | CN1161128C Anigiogenic inhibitory compounds |
| 08/11/2004 | CN1161121C Alkaloid of matrine category utilized for mainline and its preparation method |
| 08/11/2004 | CN1161113C Methods for treatment of neuro-and nephro-disorders and therapeutic toxicities using aminothiol compounds |
| 08/10/2004 | US6774237 Vascular endothelial growth factor receptor tyrosine kinases inhibitors; angiogenesis inhibitors, anticarcinogenic agents |
| 08/10/2004 | US6774228 1,4,7,10-tetrazacyclododecanes capable of reacting with monoclonal or polyclonal antibody; imaging |
| 08/10/2004 | US6774227 Reating disorders related to cellular overproliferation comprising neutralizing the production or activity of macrophage migration inhibitory factor (mif) |
| 08/10/2004 | US6774220 Compounds having lectinic properties and their biological applications |
| 08/10/2004 | US6774217 Use of fragile histidine triad gene (fhit) genes and their encoded proteins as diagnostic and therapeutic reagents for the detection and treatment of disease states associated with cell overproliferation |